Tri Locum Partners LP Legend Biotech Corp Transaction History
Tri Locum Partners LP
- $433 Million
- Q4 2024
A detailed history of Tri Locum Partners LP transactions in Legend Biotech Corp stock. As of the latest transaction made, Tri Locum Partners LP holds 388,704 shares of LEGN stock, worth $12.5 Million. This represents 2.92% of its overall portfolio holdings.
Number of Shares
388,704
Previous 362,270
7.3%
Holding current value
$12.5 Million
Previous $17.7 Million
28.35%
% of portfolio
2.92%
Previous 4.72%
Shares
9 transactions
Others Institutions Holding LEGN
# of Institutions
232Shares Held
84.2MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$241 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$219 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$192 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$184 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$183 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.38B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...